You are asking questions like a true scientist. I wish Gilead would publish the data, especially the daily leukocyte count. They may yet. They(key shareholders in nominated accounts) may sell some holdings first before allowing Gilead to publish. I came across another source of information:
https://www.dkv.global/medtech-covid?mod=article_inline
